Manning Paul B
SEC insider (Form 3/4/5 filer). CIK 0001494695. Director at Candel Therapeutics, Inc. (CADL) and 3 other issuers. 33 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in NEEDHAM, MA.
Companies Manning Paul B has filed insider reports for
- Candel Therapeutics, Inc. (CADL): Director
- Liquidia Corp (LQDA): Director
- Verrica Pharmaceuticals Inc. (VRCA): Director, 10% Owner
- Taysha Gene Therapies, Inc. (TSHA): 10% Owner
Manning Paul B
CIK: 0001494695
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (33 total)
- Sep 30, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
2.2K shares at avg. $8.68- - Jun 30, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
2.2K shares at avg. $8.64- - Jun 23, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
32K shares- - Jun 16, 2026LQDA
Liquidia Corp
AwardDirect5.9K shares- - Jun 4, 2026LQDA
Liquidia Corp
SaleIndirect11.5K shares at avg. $63.13$727K - Jun 4, 2026LQDA
Liquidia Corp
SaleIndirect88.5K shares at avg. $64.28$5.7M - Jun 4, 2026LQDA
Liquidia Corp
SaleIndirect12.6K shares at avg. $64.42$812K - Jun 4, 2026LQDA
Liquidia Corp
SaleIndirect68.3K shares at avg. $63.83$4.4M - Jun 4, 2026LQDA
Liquidia Corp
SaleIndirect19.1K shares at avg. $62.62$1.2M - Mar 31, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
4.6K shares at avg. $4.11-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 |  CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 2,189 | $8.68 | - | Direct |
| Jun 30, 2026 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 2,199 | $8.64 | - | Direct |
| Jun 23, 2026 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 32,000 | - | - | Direct |
| Jun 16, 2026 |  LQDA Liquidia Corp | Award | 5,882 | - | $0 | Direct |
| Jun 4, 2026 | LQDA Liquidia Corp | Sale | 11,513 | $63.13 | $726,816 | Indirect |
| Jun 4, 2026 | LQDA Liquidia Corp | Sale | 88,487 | $64.28 | $5,687,944 | Indirect |
| Jun 4, 2026 | LQDA Liquidia Corp | Sale | 12,610 | $64.42 | $812,336 | Indirect |
| Jun 4, 2026 | LQDA Liquidia Corp | Sale | 68,265 | $63.83 | $4,357,355 | Indirect |
| Jun 4, 2026 | LQDA Liquidia Corp | Sale | 19,125 | $62.62 | $1,197,608 | Indirect |
| Mar 31, 2026 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 4,618 | $4.11 | - | Direct |
1-10 of 33 transactions